Newly proposed framework marks a major step forward and is expected to improve care for the millions of people affected by a traumatic brain injury each year. Milwaukee, Wis.– Traumatic brain injury ...

Tough to diagnose, TBI is even tougher to study. It presents differently across individuals, and people recover (or don't) in ...

Even with mild traumatic brain injury, ... Diseases & Conditions Neurocritical Care for Severe Pediatric Traumatic Brain Injury; 2002 1184178-overview ...

Clinicians who work with elite college athletes and military cadets should be aware of the association between higher body ...

In the study, the team compared data from patients who were treated in hospital for a TBI (anything from a mild concussion to ...

Parts of the News 3 Now coverage area could see severe weather to end Sunday. Details on who and timing here. Read more. Isolated storm chance Saturday night Staying hot and humid Sunday, severe ...

MEMPHIS, Tenn. - Over the next few days, rain chances will be increasing all thanks to a weakening of this heat dome that has been parked over the Mid-South for ...

No severe weather is expected but a pockets of lightning and moderate to heavy rain are possible. Keep an eye to the sky if outdoors today. Isolated pockets of showers and weak storms possible Monday ...

Cold sensation, goose bumps, unable to perform complex tasks with hands, shiver can be mild to severe, hands numb: Moderate Hypothermia: 95º - 93ºF: Shivering, intense, muscle incoordination becomes ...

Severe thunderstorms will be possible Sunday evening into early Monday, details here. Read more. ALERT DAY Sunday for strong winds, hail and heavy rains Showers and thunderstorms possible Monday ...

Learn about Alzheimer's Disease symptoms such as memory loss and senile dementia. Find out about the treatments and causes, as well as the stages of Alzheimer's Disease and dementia.

New study results with GSK's anti-IL-5 antibody Nucala in chronic obstructive pulmonary disease (COPD) have been published, just ahead of an FDA decision on the new indication scheduled for 7th May.